Market Overview

Quidel Receives CE Mark for Its Sofia Strep A Fluorescent Immunoassay Test


Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received the CE Mark for its Sofia Strep A FIA for use with its Sofia Analyzer. Sofia is the brand name for Quidel's next generation, immunoassay system. The Sofia Analyzer and Sofia Strep A FIA combine unique fluorescent chemistry, advanced lateral flow technology, and failure alert and fail-safe systems to ensure a reliable, objective, rapid and highly accurate diagnostic result. This press release follows closely on the recent announcement (October 26th) of the FDA clearance of the Sofia Analyzer and Sofia Influenza A+B FIA.

Posted-In: News Events


Related Articles (QDEL)

View Comments and Join the Discussion!

Partner Center